Related Experiment Video
Updated: Jul 15, 2025
07:32
Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine
Published on: October 7, 2014
9.7K
Beta-Adrenergic Agonists, Dietary Protein, and Rumen Bacterial Community Interactions in Beef Cattle: A Review
Alison P Pfau1, Elizabeth A Shepherd1, M Gabbi Martin1
1Department of Animal Science, University of Tennessee, Knoxville, TN 37996, USA.
Veterinary Sciences
|September 27, 2023
Summary
Optimizing beef production involves balancing beta-adrenergic agonists, dietary protein, and microbiome technologies. This approach enhances efficiency, sustainability, and food security in cattle farming.
Area of Science:
- Animal Science
- Nutritional Science
- Microbiology
Background:
- Global demand for beef necessitates improvements in production efficiency and sustainability.
- Beta-adrenergic agonists and dietary protein are key factors influencing beef cattle growth and carcass quality.
- The role of microbiome technologies in optimizing cattle health and performance is increasingly recognized.
Purpose of the Study:
- To review the interactions between beta-adrenergic agonists, dietary protein (level and source), and the ruminal microbiome in beef cattle.
- To explore how optimizing these factors can enhance beef production efficiency and sustainability.
Main Methods:
- Literature review synthesizing current research on beta-adrenergic agonists, dietary protein, and ruminal microbiome interactions.
- Analysis of how these components influence nutrient utilization, rumen fermentation, and overall cattle performance.
Main Results:
- Beta-adrenergic agonists improve growth and feed efficiency, while dietary protein is essential for muscle development.
- Microbiome technologies optimize rumen function, nutrient absorption, and gut health, further enhancing feed efficiency.
- Synergistic effects among these factors offer potential for increased energy capture and improved cattle performance.
Conclusions:
- A balanced approach integrating beta-adrenergic agonists, appropriate dietary protein, and microbiome modulation can significantly improve beef production.
- Adoption of innovative technologies and sustainable practices is crucial for a secure and environmentally responsible beef industry.
- Continued research is vital for developing novel solutions benefiting producers and the environment.
More Related Videos
00:06Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
7.1K
11:02The Use of an Automated System GreenFeed to Monitor Enteric Methane and Carbon Dioxide Emissions from Ruminant Animals
Published on: September 7, 2015
22.0K
Related Concept Videos
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
185
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
185
01:18Amino Acid Catabolism
43
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
43
01:26Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
881
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
881
01:16Protein-Drug Binding: Mechanism and Kinetics
561
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
561
01:17Antihypertensive Drugs: Action of β1 Blockers
469
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
469